• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Investing Is it too late to invest in the Biotech stocks?
Investing

Is it too late to invest in the Biotech stocks?

by November 22, 2022
by November 22, 2022 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

“IBB” – the iShares Biotechnology ETF has already recovered about 30% over the past five months but Jefferies’ Michael Yee is convinced it still has more room to the upside.

Yee’s bull case for the biotech stock

Yee sees several catalysts that could potentially push these stocks further up in the coming months.

To begin with, biotech had a strong third quarter and more importantly, notable names in this space raised their guidance as well. That signals continued strength. Yee is also bullish because:

The visibility on cancer drugs and new diabetes drugs and new obesity drugs is pretty [clear] over the next twelve months. So, we think it’s been a great place to be, but we still think there’s more to go.

On top of that, inflation seems to be coming down as Invezz reported here. In response, if the Fed chooses to “pause”, it will create a better macroeconomic environment for the biotech stocks as well.

Biotech stocks are still not expensive

Versus the start of 2022, IBB is still down more than 10%.

And that makes up for another reason why Yee recommends investing in this exchange-traded fund. On CNBC’s “Power Lunch”, he said:

These stocks were super cheap. Even though they’re up 30% to 40% off the bottom, they’re still not expensive. So, we still think there’s room to go.

In terms of individual names, he’s particularly bullish on the likes of Gilead Sciences Inc (NASDAQ: GILD) that’s still trading well below the average of its price-to-earnings ratio for the past five years.

The post Is it too late to invest in the Biotech stocks? appeared first on Invezz.

You Might Also Like
  • How LEAPS Differ From Short-Term Options
  • 2 takeaways after area PMIs hint at a brighter inflation outlook
  • OPEC+ agrees against cutting oil production further: sell oil stocks?
  • Mizuho’s Dan Dolev is ‘super excited’ about this fintech stock
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Walgreens stock price forecast: Cowen sees another 30% upside
next post
Is corrupt Glencore a good buy after rising by 40% YTD?

You may also like

Ontario Teachers’ Pension Plan Board Acquires 25% of SSE’s Electricity...

November 25, 2022

4 takeaways after the last Federal Reserve rate hike

December 15, 2022

2 takeaways from the last NFP report of 2022

December 5, 2022

Novavax shares opened 20% down on Thursday: this is why

December 15, 2022

European Union Members Divided Over a Proposal to Cap Gas...

November 23, 2022

Sophie Karp names her top stock for renewables exposure

December 29, 2022

What to expect from the eurozone economy in 2023

November 30, 2022

Amazon attempts to break below support, but Evercore thinks it’s...

December 20, 2022

7 Helpful Tips To Invest Your Money And Time In...

March 25, 2025

Should you buy JPMorgan stock after its Q4 earnings?

January 13, 2023

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • SMCI Stock Surges: How to Invest Wisely Now

      June 26, 2025
    • NEW! 5 Significant Additions to Our Professionally-Curated Market Summary Dashboard

      June 26, 2025
    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks

      June 26, 2025
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

      June 26, 2025
    • From Drift to Lift: Spotting Breakouts Before Momentum Hits

      June 26, 2025

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 3,612 views
    • 2

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,894 views
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,586 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,549 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,428 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,151)
    • Investing (538)
    • Stock (2,635)

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 2

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • SMCI Stock Surges: How to Invest Wisely Now

      June 26, 2025
    • NEW! 5 Significant Additions to Our Professionally-Curated Market Summary Dashboard

      June 26, 2025
    • Divided Fed proposes rule to ease capital requirements for big...

      June 26, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,151)
    • Investing (538)
    • Stock (2,635)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Jim Cramer sees more upside in...

    December 1, 2022

    DAM Finance releases testnet for its...

    December 2, 2022

    Generac stock has upside to $160:...

    December 28, 2022
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here